In patients with psoriatic arthritis receiving secukinumab treatment, higher levels of beta-defensin 2 may enhance clinical response.

Published Date: 03 Jul 2023

There may be a biomarker that could be used to predict the response to, according to a recent study published in Rheumatic and Musculoskeletal Diseases.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot